Rheumatoid Arthritis: Symptoms, Causes & Treatment

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the synovial lining of joints, causing persistent inflammation. Unlike osteoarthritis, which results from cartilage wear, RA arises from a defect in the body's immune response. It is characterized by symmetrical pain (affecting both sides of the body equally) in small joints such as fingers, wrists, and ankles.

The disease affects 0.5-1% of the global population and is more common in women than men (ratio 3:1), typically appearing between ages 40-60, though it can affect younger individuals. In Jordan and the Arab region, the prevalence is rising, particularly among women. If left untreated, RA can cause permanent joint deformity and physical disability, but modern treatments have significantly reduced disease complications.

Treatment of rheumatoid arthritis relies on early diagnosis and rapid control of inflammation using medications such as methotrexate, biological agents (such as TNF inhibitors or IL-6 inhibitors), and newer targeted therapies like JAK inhibitors. The primary goal is to achieve remission or very low disease activity to prevent deformity and improve quality of life.

Symptoms of rheumatoid arthritis vary in severity and affected joints between individuals and may develop gradually over weeks or months. Some symptoms may be more pronounced in women compared to men, and symptoms may change depending on disease phases (high activity or remission).

• Joint pain: Pain in small joints (fingers, wrists, ankles) typically occurring symmetrically on both sides of the body.
• Joint swelling: Obvious soft swelling around affected joints.
• Redness and warmth: Affected joints may appear red and feel warm to the touch.
• Morning stiffness: Difficulty moving joints immediately after waking, may last an hour or more.
• Reduced range of motion: Difficulty moving affected joints and restricted movement.
• General fatigue: Feeling of tiredness and exhaustion even at rest.
• Low-grade fever: Slight elevation in body temperature during active flares.
• Loss of appetite: May occur during periods of high disease activity.
• Unintentional weight loss: May occur in active cases.
• Progressive deformities: If untreated, permanent joint deformities may develop (such as finger deviation).
• Depression and anxiety: May accompany physical symptoms.
• Sleep problems: Pain and fatigue may affect sleep quality.

• Genetic factors: Presence of specific genes (HLA-DR4 or HLA-DR1) increases disease susceptibility, especially in individuals with a positive family history.
• Immune system dysfunction: A defect in distinguishing self from non-self cells causes the body to mistakenly attack joint tissues.
• Environmental factors: Exposure to certain viral or bacterial infections (such as Epstein-Barr virus or specific bacteria) may trigger the disease in genetically predisposed individuals.
• Smoking: A significant risk factor that increases incidence and worsens disease severity.
• Hormonal changes: Changes in hormone levels (especially menopause in women) affect disease activity and severity.
• Obesity: Excess weight is associated with increased risk and worsened inflammation.
• Stress and psychological strain: May affect the immune system and increase disease activity.
• Diet: High intake of saturated fats and sugars may increase inflammation.

• Female sex: Women are 2-3 times more likely to develop the disease than men.
• Age: Most common between ages 40-60, but can occur at any age.
• Family history: Having first-degree relatives with RA significantly increases risk.
• Active or passive smoking: One of the strongest modifiable risk factors.
• Obesity and overweight: Particularly before disease onset.
• Exposure to infection: Certain viral infections may trigger the disease.
• Physical inactivity: Sedentary lifestyle increases inflammation.
• High stress levels: Chronic stress affects immune function.
• Poor nutrition: Deficiency in certain minerals and vitamins may facilitate disease.
• Excessive alcohol: May impair immune function.

Diagnosis of rheumatoid arthritis relies on a combination of clinical examination, laboratory tests, and medical imaging. Early and accurate diagnosis is crucial for initiating treatment promptly and preventing deformity. No single test definitively confirms the diagnosis; instead, specific diagnostic criteria are used.

• Clinical examination: The physician examines joints for pain, swelling, redness, warmth, and restricted movement. Duration of symptoms (at least one week required) and distribution are assessed.
• Rheumatoid Factor (RF) test: A blood test detecting specific protein in the blood. Normal value is less than 14 IU/mL. Presence of rheumatoid factor does not confirm the disease alone but supports it.
• Anti-CCP antibody test: A more specialized and sensitive test detecting specific antibodies. Normal value is less than 20 U/mL. Presence of this test strongly suggests the disease.
• Erythrocyte Sedimentation Rate (ESR): A test measuring red blood cell sedimentation speed. Normal value is less than 20 mm/hr for women and less than 15 mm/hr for men. Values rise in active cases.
• C-Reactive Protein (CRP): A test measuring inflammation in the body. Normal value is less than 10 mg/L. Elevates during disease activity.
• X-ray imaging: Used to assess joint damage severity, particularly to detect deformities and bone erosion in advanced cases.
• Ultrasound imaging: A modern and sensitive imaging technique detecting inflammation and early deformities before they appear on standard X-rays.
• Magnetic Resonance Imaging (MRI): Provides detailed images of joints and surrounding tissues, useful for assessing damage degree and inflammation.

Medications

• Disease-Modifying Antirheumatic Drugs (DMARDs): Such as methotrexate (most common first choice), sulfasalazine, and leflunomide. Work to slow disease progression and reduce inflammation long-term. Usually given orally or by injection.
• Biological agents: Such as TNF inhibitors (Adalimumab, Etanercept, Infliximab, Certolizumab), IL-6 inhibitors (Tocilizumab), and integrin inhibitors (Abatacept). Usually given by subcutaneous or intravenous injection.
• JAK Inhibitors: Modern medications such as Baricitinib, Tofacitinib, and Upadacitinib given orally, targeting specific inflammatory pathways.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Such as ibuprofen, naproxen, and indomethacin, used for short-term pain and inflammation control but do not affect long-term disease progression.
• Corticosteroids: Such as prednisone used in low doses for rapid inflammation control while waiting for DMARD effects; typically not used alone for long-term treatment.

Procedures

• Joint steroid injections: Direct injection into severely affected joints for rapid pain and swelling relief.
• Joint lavage: A procedure in which the joint is flushed to remove inflammation and debris.
• Physical therapy and rehabilitation: Customized exercise programs to improve muscle strength, joint flexibility, and functional ability.
• Surgery: May be performed in advanced cases to repair or replace severely deformed joints (knee or hip replacement).

Lifestyle Changes

• Rest and balanced activity: Avoid excessive joint stress while maintaining regular moderate activity.
• Protective devices and aids: Use special assistive tools (such as jar openers and comfortable grips) to facilitate daily tasks.
• Heat and cold application: Use warm compresses to relieve pain and stiffness, cold compresses for acute swelling.
• Anti-inflammatory diet: Eat fatty fish rich in omega-3, fruits and vegetables, whole grains. Reduce processed foods and saturated fats.
• Weight loss: If overweight, losing weight reduces pressure on joints and inflammation.
• Smoking cessation: One of the most important steps to improve disease course.
• Stress management: Mindfulness, relaxation, and enjoyable activities reduce stress that may worsen disease.
• Adequate sleep: Good sleep (7-9 hours) is essential for reducing inflammation.

• Permanent joint deformities: If not treated effectively, the disease may lead to permanent deformities such as finger deviation and curvature, significantly affecting functional ability.
• Osteoporosis: Chronic inflammation and some medications (especially corticosteroids) may lead to bone density loss, increasing fracture risk.
• Heart disease and blood clots: The disease increases risk of heart disease, stroke, and blood clots.
• Recurrent infections: Immunosuppressive medications may increase risk of serious infections.
• Secondary Sjögren's syndrome: May accompany rheumatoid arthritis causing dry eyes and mouth.
• Lung inflammation and pleural effusion: The disease may affect the lungs and cause breathing difficulty.
• Vasculitis: A rare but serious complication that may affect blood vessels in multiple body areas.
• Depression and anxiety: Chronic pain and disability may affect mental health.

• Quit smoking or never start: Smoking significantly increases disease risk and complications; quitting improves disease course.
• Maintain healthy weight: Keeping BMI between 18.5-24.9 reduces inflammation and risk factors.
• Practice regular physical activity: Moderate exercise (such as walking, swimming, yoga) three times weekly strengthens muscles and improves overall health.
• Follow a healthy anti-inflammatory diet: Fatty fish, nuts, fresh fruits and vegetables, and olive oil reduce inflammation.
• Manage stress and psychological strain: Practicing relaxation, meditation, and positive social relationships reduce stress that may trigger disease.
• Get adequate and regular sleep: Sleeping 7-9 hours daily boosts immunity and reduces inflammation.
• Avoid infection when possible: Good hygiene and recommended vaccinations reduce infection risk that may trigger disease.
• Avoid excessive alcohol: Excess alcohol weakens immune function and liver health.
• Regular medical follow-up: Especially for individuals with positive family history, to detect early disease signs.
• Reduce exposure to harmful environmental factors: Avoid pollutants, strong fragrances, and harmful chemicals.